Cerebral visual impairment and intellectual disability caused by PGAP1 variants
Daniëlle G M Bosch1,2,3,4, F Nienke Boonstra2,4, Taroh Kinoshita5
1Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Insights
Novel variants in the PGAP1 gene were identified in a boy with intellectual disability and cerebral visual impairment. These findings confirm a functional loss of PGAP1, linking it to these neurological conditions.
Area of Science:
- Genetics
- Neuroscience
- Biochemistry
Background:
- Post-translational modification of proteins is crucial for cellular function.
- Defects in the glycosylphosphatidylinositol (GPI) anchor biosynthesis pathway lead to congenital disorders of glycosylation.
- The PGAP1 gene plays a role in the remodeling of GPI anchors.
Observation:
- Whole-exome sequencing identified compound heterozygous variants in PGAP1 in an individual with cerebral visual impairment (CVI), intellectual disability (ID), and factor XII deficiency.
- Functional studies using PGAP1-deficient Chinese hamster ovary (CHO) cells and lymphoblastoid cell lines (LCLs) demonstrated a loss of PGAP1 function.
- Mutant PGAP1 constructs failed to rescue PI-PLC resistance in deficient CHO cells, and the patient's LCLs showed no PI-PLC sensitivity.
Findings:
- Novel compound heterozygous variants, c.274_276del (p.(Pro92del)) and c.921_925del (p.(Lys308Asnfs*25)), in the PGAP1 gene were identified.
- Functional assays confirmed a complete loss of PGAP1 function in the affected individual.
- The study establishes a genetic link between PGAP1 variants and CVI, alongside ID and seizures/spasticity.
Implications:
- This research expands the known phenotypic spectrum associated with PGAP1 mutations.
- It highlights the critical role of PGAP1 in neurological development, particularly visual pathways.
- The findings provide a basis for genetic counseling and potential therapeutic strategies for individuals with PGAP1-related disorders.
Abstract:
Homozygous variants in PGAP1 (post-GPI attachment to proteins 1) have recently been identified in two families with developmental delay, seizures and/or spasticity. PGAP1 is a member of the glycosylphosphatidylinositol anchor biosynthesis and remodeling pathway and defects in this pathway are a subclass of congenital disorders of glycosylation. Here we performed whole-exome sequencing in an individual with cerebral visual impairment (CVI), intellectual disability (ID), and factor XII deficiency and revealed compound heterozygous variants in PGAP1, c.274_276del (p.(Pro92del)) and c.921_925del (p.(Lys308Asnfs*25)). Subsequently, PGAP1-deficient Chinese hamster ovary (CHO)-cell lines were transfected with either mutant or wild-type constructs and their sensitivity to phosphatidylinositol-specific phospholipase C (PI-PLC) treatment was measured. The mutant constructs could not rescue the PGAP1-deficient CHO cell lines resistance to PI-PLC treatment. In addition, lymphoblastoid cell lines (LCLs) of the affected individual showed no sensitivity to PI-PLC treatment, whereas the LCLs of the heterozygous carrier parents were partially resistant. In conclusion, we report novel PGAP1 variants in a boy with CVI and ID and a proven functional loss of PGAP1 and show, to our knowledge, for the first time this genetic association with CVI.
More Related Videos
07:11Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
Published on: May 25, 2020
07:12Development of a Gaze-Contingent Display Framework Designed for Perceptual and Oculomotor Research with Simulated Central Vision Loss
Published on: April 11, 2025
Related Concept Videos
Photoreceptors and Visual Pathways
Visual Agnosia
Prosopagnosia
Intellectual Disability
Glaucoma: Overview
Inborn Errors of Metabolism
